These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 30060063)

  • 1. Development of triglyceride-lowering drugs to address residual cardiovascular risk: strategic and clinical considerations.
    Hallén J; Sreeharan N
    Eur Heart J Cardiovasc Pharmacother; 2018 Oct; 4(4):237-242. PubMed ID: 30060063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lowering triglycerides to modify cardiovascular risk: will icosapent deliver?
    Scherer DJ; Nicholls SJ
    Vasc Health Risk Manag; 2015; 11():203-9. PubMed ID: 25848301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drugs for hypertriglyceridemia.
    Med Lett Drugs Ther; 2013 Mar; 55(1411):17-9. PubMed ID: 23467119
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence of low high-density lipoprotein cholesterol and hypertriglyceridaemia in patients treated with hypolipidaemic drugs.
    Laforest L; Souchet T; Moulin P; Ritleng C; Desamericq G; Le Jeunne P; Schwalm MS; Van Ganse E
    Arch Cardiovasc Dis; 2009 Jan; 102(1):43-50. PubMed ID: 19233108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertriglyceridemia and omega-3 fatty acids: Their often overlooked role in cardiovascular disease prevention.
    Arca M; Borghi C; Pontremoli R; De Ferrari GM; Colivicchi F; Desideri G; Temporelli PL
    Nutr Metab Cardiovasc Dis; 2018 Mar; 28(3):197-205. PubMed ID: 29397253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triglyceride-Rich Lipoproteins.
    Kockx M; Kritharides L
    Cardiol Clin; 2018 May; 36(2):265-275. PubMed ID: 29609756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein C-III: a potent modulator of hypertriglyceridemia and cardiovascular disease.
    Kohan AB
    Curr Opin Endocrinol Diabetes Obes; 2015 Apr; 22(2):119-25. PubMed ID: 25692924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Main Text.
    Kolovou GD; Watts GF; Mikhailidis DP; Pérez-Martínez P; Mora S; Bilianou H; Panotopoulos G; Katsiki N; Ooi TC; Lopez-Miranda J; Tybjærg-Hansen A; Tentolouris N; Nordestgaard BG
    Curr Vasc Pharmacol; 2019; 17(5):498-514. PubMed ID: 31060488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertriglyceridemia, an Underestimated Cardiovascular Risk Factor: An Epidemiological Study of the Rome Area.
    Volpe R; Nati G; Chiriatti A; Sabatini M; Valente F;
    High Blood Press Cardiovasc Prev; 2017 Dec; 24(4):401-404. PubMed ID: 28710676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential options to treat hypertriglyceridaemia.
    Viljoen A; Wierzbicki AS
    Curr Drug Targets; 2009 Apr; 10(4):356-62. PubMed ID: 19355860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postprandial Hypertriglyceridaemia Revisited in the Era of Non-Fasting Lipid Profile Testing: A 2019 Expert Panel Statement, Narrative Review.
    Kolovou GD; Watts GF; Mikhailidis DP; Pérez-Martínez P; Mora S; Bilianou H; Panotopoulos G; Katsiki N; Ooi TC; Lopez-Miranda J; Tybjærg-Hansen A; Tentolouris N; Nordestgaard BG
    Curr Vasc Pharmacol; 2019; 17(5):515-537. PubMed ID: 31309820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Demystifying the management of hypertriglyceridaemia.
    Watts GF; Ooi EM; Chan DC
    Nat Rev Cardiol; 2013 Nov; 10(11):648-61. PubMed ID: 24060958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of hypertriglyceridemia for prevention of atherosclerotic cardiovascular disease.
    Brinton EA
    Cardiol Clin; 2015 May; 33(2):309-23. PubMed ID: 25939302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Postprandial Hypertriglyceridaemia Revisited in the Era of Non-fasting Lipid Profiles: Executive Summary of a 2019 Expert Panel Statement.
    Kolovou GD; Watts GF; Mikhailidis DP; Pérez-Martínez P; Mora S; Bilianou H; Panotopoulos G; Katsiki N; Ooi TC; Lopez-Miranda J; Tybjærg-Hansen A; Tentolouris N; Nordestgaard BG
    Curr Vasc Pharmacol; 2019; 17(5):538-540. PubMed ID: 31418346
    [No Abstract]   [Full Text] [Related]  

  • 15. Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and Biology.
    Nordestgaard BG
    Circ Res; 2016 Feb; 118(4):547-63. PubMed ID: 26892957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated Triglyceride Level Is Independently Associated With Increased All-Cause Mortality in Patients With Established Coronary Heart Disease: Twenty-Two-Year Follow-Up of the Bezafibrate Infarction Prevention Study and Registry.
    Klempfner R; Erez A; Sagit BZ; Goldenberg I; Fisman E; Kopel E; Shlomo N; Israel A; Tenenbaum A
    Circ Cardiovasc Qual Outcomes; 2016 Mar; 9(2):100-8. PubMed ID: 26957517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A New Beginning for Triglyceride-Lowering Therapies.
    Pradhan AD
    Circulation; 2019 Jul; 140(3):167-169. PubMed ID: 30836784
    [No Abstract]   [Full Text] [Related]  

  • 18. Determining triglyceride reductions needed for clinical impact in severe hypertriglyceridemia.
    Christian JB; Arondekar B; Buysman EK; Jacobson TA; Snipes RG; Horwitz RI
    Am J Med; 2014 Jan; 127(1):36-44.e1. PubMed ID: 24384100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of triglycerides in cardiovascular risk.
    Gandotra P; Miller M
    Curr Cardiol Rep; 2008 Nov; 10(6):505-11. PubMed ID: 18950562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of K-877, a novel selective peroxisome proliferator-activated receptor α modulator (SPPARMα), in combination with statin treatment: Two randomised, double-blind, placebo-controlled clinical trials in patients with dyslipidaemia.
    Arai H; Yamashita S; Yokote K; Araki E; Suganami H; Ishibashi S;
    Atherosclerosis; 2017 Jun; 261():144-152. PubMed ID: 28410749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.